Search research articles
Contact Us
Filters
Showing results (11-20 of 89) with videos related to
Page
of 9
Sort By:
Iscience
|
September 26, 2022
Anti-viral efficacy of a next-generation CD4-binding site bNAb in SHIV-infected animals in the absence of anti-drug antibody responses
Sarah E Lovelace, Sabrina Helmold Hait, Eun Sung Yang, et al.
The Journal of Clinical Investigation
|
April 18, 2018
Accumulation of follicular CD8+ T cells in pathogenic SIV infection
Sara Ferrando-Martinez, Eirini Moysi, Amarendra Pegu, et al.
The Journal of Clinical Investigation
|
October 8, 2021
Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent staging
Joana Dias, Giulia Fabozzi, Kylie March, et al.
Nature
|
April 28, 2016
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
Rajeev Gautam, Yoshiaki Nishimura, Amarendra Pegu, et al.
JCI Insight
|
December 17, 2020
Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention
Neville K Kisalu, Lais D Pereira, Keenan Ernste, et al.
Journal of Virology
|
August 4, 2017
Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys
Boris Julg, Devin Sok, Stephen D Schmidt, et al.
Plos Pathogens
|
May 15, 2019
Delayed vaginal SHIV infection in VRC01 and anti-α4β7 treated rhesus macaques
Giulia Calenda, Ines Frank, Géraldine Arrode-Brusés, et al.
Antimicrobial Agents and Chemotherapy
|
August 27, 2025
Fostemsavir analog BMS-818251 has enhanced viral neutralization potency and similar escape mutation profile
Yen-Ting Lai, Adam S Dingens, Megan DeMouth, et al.
Journal of Virology
|
November 20, 2015
Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs
Diane L Bolton, Amarendra Pegu, Keyun Wang, et al.
Plos Pathogens
|
May 3, 2018
Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation
Ema T Crooks, Samantha L Grimley, Michelle Cully, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 89) with videos related to
Sort By:
Page
of 9
Iscience
|
September 26, 2022
Anti-viral efficacy of a next-generation CD4-binding site bNAb in SHIV-infected animals in the absence of anti-drug antibody responses
Sarah E Lovelace, Sabrina Helmold Hait, Eun Sung Yang, et al.
The Journal of Clinical Investigation
|
April 18, 2018
Accumulation of follicular CD8+ T cells in pathogenic SIV infection
Sara Ferrando-Martinez, Eirini Moysi, Amarendra Pegu, et al.
The Journal of Clinical Investigation
|
October 8, 2021
Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent staging
Joana Dias, Giulia Fabozzi, Kylie March, et al.
Nature
|
April 28, 2016
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
Rajeev Gautam, Yoshiaki Nishimura, Amarendra Pegu, et al.
JCI Insight
|
December 17, 2020
Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention
Neville K Kisalu, Lais D Pereira, Keenan Ernste, et al.
Journal of Virology
|
August 4, 2017
Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys
Boris Julg, Devin Sok, Stephen D Schmidt, et al.
Plos Pathogens
|
May 15, 2019
Delayed vaginal SHIV infection in VRC01 and anti-α4β7 treated rhesus macaques
Giulia Calenda, Ines Frank, Géraldine Arrode-Brusés, et al.
Antimicrobial Agents and Chemotherapy
|
August 27, 2025
Fostemsavir analog BMS-818251 has enhanced viral neutralization potency and similar escape mutation profile
Yen-Ting Lai, Adam S Dingens, Megan DeMouth, et al.
Journal of Virology
|
November 20, 2015
Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs
Diane L Bolton, Amarendra Pegu, Keyun Wang, et al.
Plos Pathogens
|
May 3, 2018
Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation
Ema T Crooks, Samantha L Grimley, Michelle Cully, et al.
Page
of 9